CLINICAL_TRIALS
trial_result
· 2024-09-19
Clinical Trial Update: Rapamycin Treatment for ALS [Phase 2]
Summary
A Phase 2 trial evaluating rapamycin for amyotrophic lateral sclerosis has completed. The snippet does not include trial results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Azienda Ospedaliero-Universitaria di Modena | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED